Effects of empagliflozin in different phases of diabetes mellitus-related cardiomyopathy: a prospective observational study

BACKGROUND: Diabetes mellitus-related cardiomyopathy (DMCMP), defined as left ventricular (LV) dysfunction caused by hyperglycemia in the absence of coronary artery disease, leads to heart failure (HF). Previous studies have shown that treatment with sodium-glucose co-transporter 2 inhibitor (SGLT2i...

Descripción completa

Detalles Bibliográficos
Autores principales: Oka, Satoshi, Kai, Takahiko, Hoshino, Katsuomi, Watanabe, Kazunori, Nakamura, Jun, Abe, Makoto, Watanabe, Akinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086321/
https://www.ncbi.nlm.nih.gov/pubmed/33926386
http://dx.doi.org/10.1186/s12872-021-02024-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086321/
https://www.ncbi.nlm.nih.gov/pubmed/33926386
http://dx.doi.org/10.1186/s12872-021-02024-3

Ejemplares similares